[Pathogenic mechanisms and targeted therapeutic advances of the FGF/FGFR signaling pathway in hematological malignancies].
The signaling axis composed of fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) is a core regulatory hub for the morphogenesis and homeostatic maintenance of the hematopoietic system. Accumulating evidence indicates that aberrant activation of the FGF/FGFR signaling axis contributes to ma...